Appearance of macrolide-resistant Bordetella pertussis strains in China.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed.

1. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.mSphere · 2018
   Trial
2. Global phylogenomics of Bordetella pertussis ST2 reveals regional heterogeneity in China and lineage-specific genome evolution.BMC genomics · 2026
   Article
3. Vaccines · 2026
   Review
4. Genomic insights into Bordetella pertussis evolution and macrolide resistance in Yiwu, China.BMC genomics · 2025
   Article
5. Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.Infection & chemotherapy · 2025
   Review
6. Whole-genome comparison of two same-genotype macrolide-resistant Bordetella pertussis isolates collected in Japan.PloS one · 2024
   Article
7. Genomic epidemiology and multilevel genome typing ofEmerging microbes & infections · 2023
   Article
8. The whole-cell proteome shows the characteristics of macrolides-resistant Bordetella pertussis in China linked to the biofilm formation.Archives of microbiology · 2023
   Article
9. Severe problem of macrolides resistance to common pathogens in China.Frontiers in cellular and infection microbiology · 2023
   Review
10. Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.Journal of global antimicrobial resistance · 2022
    Article
11. A Subtraction Genomics-Based Approach to Identify and Characterize New Drug Targets inVaccines · 2022
    Article
12. Macrolide Resistance inAntibiotics (Basel, Switzerland) · 2022
    Review
13. Complete Genome Sequence of a Macrolide-Resistant Bordetella pertussis Isolated in Japan.Microbiology resource announcements · 2022
    Article
14. Macrolide susceptibility and molecular characteristics ofThe Journal of international medical research · 2022
    Article
15. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.Medicine · 2021
    Article
16. Highlights of the 12th International Bordetella Symposium.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
17. iGIST-A Kinetic Bioassay for Pertussis Toxin Based on Its Effect on Inhibitory GPCR Signaling.ACS sensors · 2020
    Article
18. Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013.Emerging infectious diseases · 2020
    Article
19. Macrolide-Resistant Bordetella pertussis, Vietnam, 2016-2017.Emerging infectious diseases · 2020
    Article
20. Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

10 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as